Free Trial

Co-Diagnostics (CODX) Competitors

Co-Diagnostics logo
$0.26 -0.02 (-5.78%)
Closing price 04:00 PM Eastern
Extended Trading
$0.27 +0.01 (+2.68%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CODX vs. NMTC, COCH, TMDIF, DRIO, OSRH, BDMD, FEMY, VVOS, PETV, and RVP

Should you be buying Co-Diagnostics stock or one of its competitors? The main competitors of Co-Diagnostics include NeuroOne Medical Technologies (NMTC), Envoy Medical (COCH), Titan Medical (TMDIF), DarioHealth (DRIO), OSR (OSRH), Baird Medical Investment (BDMD), Femasys (FEMY), Vivos Therapeutics (VVOS), PetVivo (PETV), and Retractable Technologies (RVP). These companies are all part of the "medical equipment" industry.

Co-Diagnostics vs. Its Competitors

NeuroOne Medical Technologies (NASDAQ:NMTC) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment.

NeuroOne Medical Technologies has a net margin of -75.41% compared to Co-Diagnostics' net margin of -1,025.45%. Co-Diagnostics' return on equity of -60.16% beat NeuroOne Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
NeuroOne Medical Technologies-75.41% -334.64% -124.42%
Co-Diagnostics -1,025.45%-60.16%-52.69%

NeuroOne Medical Technologies presently has a consensus price target of $1.45, suggesting a potential upside of 98.36%. Co-Diagnostics has a consensus price target of $5.50, suggesting a potential upside of 2,007.28%. Given Co-Diagnostics' higher probable upside, analysts clearly believe Co-Diagnostics is more favorable than NeuroOne Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeuroOne Medical Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Co-Diagnostics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00

16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are held by institutional investors. 8.9% of NeuroOne Medical Technologies shares are held by company insiders. Comparatively, 6.1% of Co-Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

NeuroOne Medical Technologies has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Comparatively, Co-Diagnostics has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500.

NeuroOne Medical Technologies has higher earnings, but lower revenue than Co-Diagnostics. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeuroOne Medical Technologies$3.45M10.56-$12.32M-$0.22-3.32
Co-Diagnostics$3.91M2.24-$37.64M-$1.17-0.22

In the previous week, NeuroOne Medical Technologies' average media sentiment score of 0.00 equaled Co-Diagnostics'average media sentiment score.

Company Overall Sentiment
NeuroOne Medical Technologies Neutral
Co-Diagnostics Neutral

Summary

NeuroOne Medical Technologies beats Co-Diagnostics on 7 of the 13 factors compared between the two stocks.

Get Co-Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CODX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CODX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CODX vs. The Competition

MetricCo-DiagnosticsMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$8.76M$7.24B$5.45B$8.93B
Dividend YieldN/A2.78%5.22%4.01%
P/E Ratio-0.2226.9227.2420.06
Price / Sales2.2432.06426.37117.54
Price / CashN/A20.3926.2128.59
Price / Book0.156.687.925.56
Net Income-$37.64M$230.16M$3.17B$248.56M
7 Day Performance-6.85%1.48%4.40%7.56%
1 Month Performance-13.03%0.36%2.64%8.54%
1 Year Performance-79.12%37.58%35.04%21.81%

Co-Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CODX
Co-Diagnostics
3.674 of 5 stars
$0.26
-5.8%
$5.50
+2,007.3%
-77.0%$8.76M$3.91M-0.22100Gap Up
NMTC
NeuroOne Medical Technologies
2.1989 of 5 stars
$0.68
-0.3%
$1.45
+113.8%
-11.1%$33.88M$5.76M-3.0820
COCH
Envoy Medical
2.7971 of 5 stars
$1.42
-7.2%
$9.25
+551.4%
-32.7%$32.63M$212K-1.0334
TMDIF
Titan Medical
N/A$0.29
flat
N/A+600.0%$32.62M$17.63M-0.2350Gap Down
DRIO
DarioHealth
1.3687 of 5 stars
$0.67
flat
$2.00
+198.5%
-40.0%$29.79M$27.04M-1.20200
OSRH
OSR
N/A$1.38
+2.2%
N/AN/A$26.02MN/A0.00N/AGap Up
BDMD
Baird Medical Investment
N/A$3.66
-6.2%
N/AN/A$25.68MN/A0.00N/ANews Coverage
Analyst Upgrade
High Trading Volume
FEMY
Femasys
3.833 of 5 stars
$0.97
-1.4%
$8.67
+797.4%
-15.9%$25.04M$1.63M-1.0630
VVOS
Vivos Therapeutics
0.7659 of 5 stars
$3.16
-3.7%
$4.82
+52.4%
+83.9%$19.32M$15.03M-1.83160
PETV
PetVivo
N/A$0.80
+1.3%
N/A+69.6%$19.17M$1.05M-1.7820Gap Down
High Trading Volume
RVP
Retractable Technologies
2.0557 of 5 stars
$0.64
+3.1%
N/A-44.4%$18.56M$33.75M-1.18240

Related Companies and Tools


This page (NASDAQ:CODX) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners